Increasing awareness and knowledge of Alpha-gal Syndrome in the United States

forecasted

The purpose of this NOFO is to improve awareness and knowledge of alpha-gal syndrome (AGS) in the United States. AGS is an emerging condition and is not nationally notifiable. This NOFO seeks to improve AGS surveillance, patient care, and public awareness and understanding.The NOFO strategies are to:(1) TRACK – Conduct public health surveillance for AGS. This strategy could involve patient populations or geographic locations with limited access to specialized healthcare provider care. Health equity impacts should be considered.(2) EDUCATE – Create AGS communications targeted at the general public, AGS patients, or persons at higher risk for tick encounters (outdoor enthusiasts, dog owners, etc.). Communications targeted at healthcare providers, healthcare provider educational resources, and training would also fall under this strategy.(3) SHARE – Disseminate latest knowledge of AGS among stakeholders, including public health agencies, academic researchers, and advocacy groups, in order to improve patient care for AGS and the public health response.